Real-world Experience Using Cabotegravir Long-Acting for HIV-1 Pre-exposure Prophylaxis in the United States From Cross-sectional Surveys and Retrospective Chart Reviews: Results From the CAPTIVATE Study

Conference Reports for NATAP

13th IAS Conference on HIV Science
IAS 2026
July 26-31 Rio, Brazil


Real-world Experience Using Cabotegravir Long-Acting for HIV-1 Pre-exposure Prophylaxis in the United States From Cross-sectional Surveys and Retrospective Chart Reviews: Results From the CAPTIVATE Study

	AS 2026 Rio, Brazil